Delivery Order SPE2DB24D2003-SPE2DB25FXKA7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $36,552.67 delivery order to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhaler (12 grams) on September 10, 2025, with completion expected by September 11, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a discrete purchase order under AmerisourceBergen's existing pharmaceutical supply agreements with the federal government. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $5,989.74 to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 microgram inhalers (12-gram containers). The contract was competitively awarded with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of October 24, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,068.76 to AmerisourceBergen Drug Corp for Advair HFA 45-21 microgram inhalers (12 grams) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $10,402.76 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Advair HFA 115-21 microgram inhaler 12-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Advair HFA 115-21 micrograms inhalers (12-gram units) with a ceiling value of $2,208.80. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Advair HFA 230/21 microgram inhalers in 12-gram units, with a contract ceiling value of $1,608.05. This firm fixed-price delivery order, which is due for completion by August 29, 2025, represents a non-competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The pharmaceutical product will...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,956.40 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Advair HFA 230-21 micrograms inhalers (12-gram units). This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a $5,726.41 delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Advair HFA 45-21 mcg inhalers (12 grams). This is a firm fixed price, non-set-aside contract with a completion date of May 5, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's Conshohocken, Pennsylvania location, where the vendor maintains its corporate...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXKA7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,546.09 to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12-gram units). This is a firm fixed-price, non-set-aside contract with a completion date of June 27, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceuticals and medical supplies to military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains, from specialty medications to generic drugs and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/26/25 |